American Vanguard earnings date
American Vanguard (AVJ) Q3 2026 Earnings Report
DE:AVJ Q3 2026 EPS Results
- Actual EPS
- -EUR 0.55
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.39
DE:AVJ Q3 2026 Revenue Results
- Actual Revenue
- EUR 97.03M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -9.17%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/09/2026
- Time
- After Close
- Conference Call
- Monday, November 9, 2026
American Vanguard's next earnings date is estimated for March 18, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call presented a mixed outlook. Management highlighted improved customer prepayments, liquidity, cost actions, new product and portfolio initiatives, and expectations for stronger fourth-quarter results. However, third-quarter revenue and EBITDA declined, gross margins contracted, international markets remained weak, transportation costs increased sharply, leverage stayed close to the covenant maximum, and full-year revenue and adjusted EBITDA guidance were reduced. The positive initiatives and fourth-quarter expectations were balanced by significant current operating and market challenges.
American Vanguard now expects full year 2026 revenue to be in the range of $500 million to $530 million and adjusted EBITDA to come in the $36 million to $40 million range; for the fourth quarter, it projects net sales of approximately $166 million, up 10% versus the year ago period, and adjusted EBITDA of $21 million, up roughly 25% versus last year's fourth quarter, while anticipating fourth quarter prepayment and early pay collections of $45 million and net working capital to be a positive contributor to liquidity. The Syngenta portfolio and Sipcam Agro distribution agreement are projected to add a total of $15 million to $20 million in annualized revenue over the next 12 months, the company’s goal remains 50 new product launches, driving $100 million in annualized revenue by 2030, and it expects to reach an annualized run rate of more than $600 million in sales by the back half of 2028, approximately 20% above our 2025 level.
- Customer Prepayments and Liquidity ImprovedCustomer prepayments increased 44% over the prior-year quarter. Cash ended the quarter at $84 million, up $40 million sequentially, while net debt was approximately $183.8 million, down $40 million sequentially. The company also reduced inventory by $4.9 million year-over-year through tighter production planning and improved sales, inventory, and operating planning processes.
- U.S. Commercial and Nine-Month PerformanceManagement said U.S. commercial execution continues to outperform. U.S. crop sales increased 3% for the first nine months, and U.S. specialty sales increased 6% over the same period.
- Manufacturing and Footprint SavingsThe Los Angeles facility rationalization was completed, with synthesis production moved to Axis, Alabama. The company expects this action to save at least $4 million annually, and the third quarter was the first full quarter of those savings. The headquarters relocation to Irvine is also complete and is expected to save approximately $0.5 million annually.
- Operating Expense ProductivityNon-GAAP operating expense was $27.8 million, down $800,000 from the third quarter of 2025, as the company realized productivity improvements from its transformation efforts while making targeted investments in its new product introduction roadmap. Transformation costs were $1.7 million, down $300,000 year-over-year.
- New Portfolio AdditionsThe company acquired four U.S. brands and registrations from Syngenta and entered into a distribution agreement with Sipcam Agro. The additions are projected to contribute a total of $15 million to $20 million in annualized revenue over the next 12 months. The Syngenta transaction included $5 million paid upfront and a $4.5 million payment due in another year, for a total acquisition value of $9.5 million.
- New Product Launch ProgressAmerican Vanguard launched 10 new products year-to-date and plans to launch Duro LQ, a liquid-based corn insecticide, in the U.S. during the fourth quarter. The company reiterated its goal of launching 50 new products and generating $100 million in annualized revenue from them by 2030.
- Positive Performance of Flute in AustraliaFlute received a label extension to include cereals in Australia and was described as performing very well.
- Fourth-Quarter Growth ExpectationsThe company projects fourth-quarter net sales of approximately $166 million, up 10% versus the prior-year period, and adjusted EBITDA of $21 million, up roughly 25%. Management attributed the expected improvement to higher U.S. crop and specialty volumes, relatively better international performance, new product sales, better manufacturing fixed-cost absorption, Los Angeles facility savings, and further operating expense reductions.
- Debt Covenant PositionGross leverage under the first lien term loan was 6.5x at quarter-end against a covenant maximum of 6.7x. Based on fourth-quarter guidance and associated cash generation, management expects to reduce leverage by year-end.
- Longer-Term Growth and Margin ObjectivesManagement reiterated its objective of moving the EBITDA margin into double digits as soon as possible and expects to reach an annualized sales run rate of more than $600 million by the back half of 2028, approximately 20% above the 2025 goal. The company expects lower net working capital and growth to generate free cash flow that can be used to reduce net debt over the next two years.
- Management and Commercial Team AdditionsHermann Castro joined to drive new product development, Mark Helt joined as U.S. Crop President, and Matt Horwath became CFO. The company also highlighted a refocused commercial organization, including new leadership and additions in the specialty business.
DE:AVJ Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 18, 2027 | 2026 (Q4) | ―- | -0.89 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | ―-0.55 | -0.39 | -41.86% (-0.16) | |
| Aug 10, 2026 | 2026 (Q2) | ―-0.30 | -0.03 | -1033.33% (-0.28) | |
| May 06, 2026 | 2026 (Q1) | ―-0.13 | -0.27 | 53.33% (+0.14) | |
| Mar 16, 2026 | 2025 (Q4) | ―-0.89 | -2.88 | 69.25% (+2.00) | |
| Nov 10, 2025 | 2025 (Q3) | -0.07-0.39 | -0.82 | 53.26% (+0.44) | |
| Jul 31, 2025 | 2025 (Q2) | -0.10-0.03 | -0.38 | 92.86% (+0.35) | |
| Jun 06, 2025 | 2025 (Q1) | -0.06-0.27 | 0.05 | -600.00% (-0.32) | |
| Mar 14, 2025 | 2024 (Q4) | 0.18-2.88 | 0.21 | -1441.67% (-3.10) | |
| Nov 11, 2024 | 2024 (Q3) | -0.09-0.82 | -0.01 | -9100.00% (-0.81) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
